Precision Thermal Dosimetry for Andromedic HyDeep 600WM

Advanced Indirect Temperature Calculation & Patient-Centric Safety in Oncological Hyperthermia

In locoregional cancer therapy, precise thermal management is paramount to preventing adverse effects while maximizing therapeutic outcomes. The Andromedic HyDeep 600WM hyperthermia device utilizes a proprietary algorithmic ecosystem for real-time indirect temperature monitoring. This sophisticated system, combined with continuous biometric feedback, ensures high-precision targeting of tumor areas without compromising patient comfort.

Our modulated RF-hyperthermia technology is engineered to achieve optimal selective heating, ensuring that thermal sensations are strictly localized, temporary, and managed with surgical precision.

Biological Mechanisms of Targeted Hyperthermia

Tumor Environment (43°C)

Malignant tissues exhibit primitive vascularization with non-elastic vessels. Unlike healthy tissue, these vessels cannot dilate to dissipate excess thermal energy.

Therapeutic Outcome: Localized heat retention triggers apoptosis and enhances chemosensitivity through sustained thermal stress.

Healthy Tissue (38-39°C)

Normal cells possess adaptive vascularization. This elastic network responds to RF-induced heat by increasing blood flow, effectively “washing out” excess temperature.

Biological Benefit: Maintains homeostasis while stimulating the immune response, effectively acting as an “artificial fever” for systemic defense.

Clinical Validation: Heat Distribution Analytics

Scientific visualization of temperature distribution and precise control in oncologic hyperthermia
Figure 1:
Advanced thermometric modeling of temperature gradients in tumoral vs. healthy tissues (Source: MDPI Sensors, 2021).

Request Clinical Specifications

Detailed documentation on our proprietary temperature calculation algorithm is available for oncology departments and research centers.


Schedule a Technical Consultation